Danish pharma giant Novo Nordisk (NVO) will make a significant investment of approximately $1.2 billion to construct a new production facility in Odense, Denmark. The new facility will focus on ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback